Vitiligo-specific instrument on quality of life - Brazilian Portuguese version

Boza, Juliana Catucci; Giongo, Natalia Piccinini; Cestari, Tânia Ferreira

doi:10.1590/abd1806-4841.20165744

Cited by 5 publications

(4 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first questionnaire was related to social and health variables, constructed by the researchers to characterize the sample. The second, for the assessment of QoL, is called Vitiligo-Specific Quality-of-Life Instrument (VitQol) 11…”

Section: Methodsmentioning

confidence: 99%

Living With Vitiligo: Impact of the Disease on the Individuals’ Quality of Life

Domingues¹,

Silva²,

Kaizer³

et al. 2022

ESTIMA, Braz. J. Enterostomal Ther.

View full text Add to dashboard Cite

Introduction: Vitiligo is a disease characterized by asymptomatic hypochromic and/or achromic macules, localized or generalized in the integumentary system. The visible depigmentation in the skin of the individual and usually exposed in daily life changes the body image, impacting their quality of life. Objective: To evaluate the quality of life of people living with vitiligo. Method: This is a cross-sectional study carried out with 86 individuals with vitiligo. For data collection, the Vitiligo-Specific Quality-of-Life Instrument questionnaire was used for quality of life. Results: Adult women (81.4%) (mean age 39 years old) with vitiligo had a medium impact on quality of life, and the factors that interfered with quality of life are related to intensified skin care, progression, and appearance of the disease. Conclusion: The vitiligo pathology interfered in the quality of life of adults. The factors that impacted quality of life were intensified skin care in leisure activities, the progression of the disease and the appearance of hypochromic spots.

show abstract

Section: Methodsmentioning

confidence: 99%

Living With Vitiligo: Impact of the Disease on the Individuals’ Quality of Life

Domingues¹,

Silva²,

Kaizer³

et al. 2022

ESTIMA, Braz. J. Enterostomal Ther.

View full text Add to dashboard Cite

show abstract

“…Most studies that evaluated QoL in patients with vitiligo from Africa, the Middle East or Latin America used the DLQI 21 , 33 , 51 , 52 , 53 , 54 and/or the Vitiligo‐specific QoL instrument (VitiQoL). 33 , 51 , 53 , 55 , 56 , 57 , 58 Multiple DLQI translations are available, including Arabic and Portuguese versions. 9 , 54 , 59 An Egyptian Arabic version of the Skindex‐16 60 is also available.…”

Section: Burden Of Vitiligo In Africa the Middle East And Latin Americamentioning

confidence: 99%

Prevalence and burden of vitiligo in Africa, the Middle East and Latin America

Al Hammadi,

Silva de Castro,

Parmar

et al. 2023

Skin Health and Disease

View full text Add to dashboard Cite

Vitiligo is a common chronic autoimmune disorder characterized by skin and hair depigmentation that affects 0.5%–2.0% of the global population. Vitiligo is associated with diminished quality of life (QoL) and psychosocial burden. The burden of vitiligo may vary based on skin tone and cultural differences as well as geographical variations in disease awareness, societal stigma, healthcare systems and treatment options. Data on the burden and management of vitiligo in Africa, the Middle East and Latin America are scarce. Literature searches using terms covering vitiligo in Africa, the Middle East and Latin America were conducted using PubMed to identify relevant publications that focused on disease prevalence and burden, QoL and psychosocial impact and disease management between 2011 and 2021. Most of the reviewed studies were conducted in the Middle East, and most Latin American studies were from Brazil. Most studies involved small patient numbers and may not be generalizable. Reported prevalence of vitiligo ranged from 0.18% to 5.3% in Africa and the Middle East, and from 0.04% to 0.57% in Latin America. In several studies, prevalence was higher among female participants. Generally, non‐segmental vitiligo was the dominant clinical variant identified and the age at onset varied widely across studies. Common comorbidities include autoimmune diseases such as Hashimoto's thyroiditis, alopecia areata and diabetes. Few treatment guidelines exist in these regions, with the exceptions of guidelines published by the Brazilian and Argentinian Societies of Dermatology. There is a clear unmet need for large epidemiological studies with uniform methodology to accurately ascertain the true prevalence of vitiligo in Africa, the Middle East and Latin America. Additional data on vitiligo burden and management in Africa and Latin America are also needed, along with local disease management guidelines that consider genetic variation, psychosocial burden and socioeconomic diversity in all 3 regions.

show abstract

“…All of these cause impairments in Children's Dermatology Quality of life Index (CDLQI). 39 Dertlioglu et al 40 compared the QoL of 50 children with vitiligo and 50 children with atopic dermatitis and healthy controls who were matched for age and sex. Patients with vitiligo had significantly higher CDLQI scores when compared with healthy controls and also patients with atopic dermatitis.…”

Section: Childhood Vitiligomentioning

confidence: 99%

Vitiligo: A black patch on white skin is a blessing—but a white patch on black skin is a curse

Ghia

Mysore²

2022

Dermatological Reviews

View full text Add to dashboard Cite

Background Vitiligo is one of the most common skin disorders of possible autoimmune etiology, causing serious cosmetic, psychological, financial, social problems, and affecting the quality of life. There is a lack of recognition of the sufferings of these patients as it is neither visible nor obvious in the fair‐skinned population. Treatment modalities too are varied and there is still a lack of expertise among physicians treating the disease. Objective To highlight the magnitude of the suffering due to Vitiligo and the need for its recognition for greater efforts by governmental and nongovernmental agencies to address the issues surrounding this disease. Conclusion Vitiligo affects the quality of life by its chronicity, visibility, and relapsing nature. The treatments are often expensive, and not easily accessible. There is a need for greater research to develop more effective modalities through the involvement of international organizations and better coordination with the private sector and patient groups to make information and treatments available, accessible, and economical for all patients.

show abstract

Vitiligo-specific instrument on quality of life - Brazilian Portuguese version

Cited by 5 publications

References 2 publications

Living With Vitiligo: Impact of the Disease on the Individuals’ Quality of Life

Living With Vitiligo: Impact of the Disease on the Individuals’ Quality of Life

Prevalence and burden of vitiligo in Africa, the Middle East and Latin America

Vitiligo: A black patch on white skin is a blessing—but a white patch on black skin is a curse

Contact Info

Product

Resources

About